Showing results (521-530 of 547) with videos related to

Sort By:
Pageof 55
European Journal of Nuclear Medicine and Molecular Imaging|December 20, 2017
The diagnostic value of 18F-FDG-PET/CT and MRI in suspected vertebral osteomyelitis - a prospective studyIlse J E Kouijzer, Henk Scheper, Jacky W J de Rooy, et al.
Cancers|September 23, 2022
Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal CancerLisa S M Hofste, Maartje J Geerlings, Daniel von Rhein, et al.
European Journal of Preventive Cardiology|April 9, 2025
Lifestyle behaviour change of patients following cardiac rehabilitation: the BENEFIT intervention study with one-year follow-upLinda D Breeman, Veronica R Janssen, Roderik A Kraaijenhagen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2025
A cost-effectiveness study of PSMA-PET/CT for the detection of clinically significant prostate cancerBastiaan M Privé, Tim M Govers, Bas Israël, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2019
Accuracy of 18F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal CancerMaria J Valkema, Bo Jan Noordman, Bas P L Wijnhoven, et al.
Nature Cell Biology|August 30, 2018
IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonizationZafira Castaño, Beatriz P San Juan, Asaf Spiegel, et al.
Heart & Lung : the Journal of Critical Care|September 18, 2024
Modifiable risk factors and motivation for lifestyle change of CVD patients starting cardiac rehabilitation: The BENEFIT studyLinda D Breeman, Andrés Pérez-Alonso, David Kühling-Romero, et al.
Environmental Science & Technology|July 17, 2009
Fate and effects of CeO2 nanoparticles in aquatic ecotoxicity testsKaren Van Hoecke, Joris T K Quik, Joanna Mankiewicz-Boczek, et al.
Radiology|May 21, 2024
Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate CancerBastiaan M Privé, Bas Israël, Marcel J R Janssen, et al.
Frontiers in Nuclear Medicine|October 2, 2024
An Update to the Pilot Study of 177Lu-PSMA in Low Volume Hormone-Sensitive Prostate CancerBastiaan M Privé, Constantijn H J Muselaers, Inge M van Oort, et al.
Pageof 55